155 related articles for article (PubMed ID: 38395897)
1. Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
Hoesseini A; Sewnaik A; van den Besselaar BN; Zhang J; van Leeuwen N; Hardillo JA; Baatenburg de Jong RJ; Offerman MPJ
BMC Palliat Care; 2024 Feb; 23(1):54. PubMed ID: 38395897
[TBL] [Abstract][Full Text] [Related]
2. Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
Hoesseini A; van Leeuwen N; Offerman MPJ; Zhang J; Dronkers EAC; Sewnaik A; Lingsma HF; Baatenburg de Jong RJ
Head Neck; 2021 Aug; 43(8):2445-2456. PubMed ID: 33960553
[TBL] [Abstract][Full Text] [Related]
3. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis.
Zhu RQ; Zhang YM; Luo XY; Shen WY; Zhu HY
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1467-1478. PubMed ID: 36316576
[TBL] [Abstract][Full Text] [Related]
4. Treatment Outcome in Head and Neck Cancer With Distant Metastasis at Initial Diagnosis.
Omata J; Ueki Y; Takahashi Y; Tanaka R; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Togashi T; Matsuyama H; Takahashi N; Okabe R; Horii A
Laryngoscope; 2024 Apr; 134(4):1679-1686. PubMed ID: 37698411
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the accuracy of clinical prediction of survival and palliative prognostic index for patients with head and neck squamous cell carcinoma in the end-of-life setting.
Kishino T; Monden N; Akisada N; Hayashi Y; Nakamura M; Hashimoto K; Miyashita T; Mori T; Hoshikawa H
Auris Nasus Larynx; 2022 Feb; 49(1):133-140. PubMed ID: 34226098
[TBL] [Abstract][Full Text] [Related]
6. Physicians' clinical prediction of survival in head and neck cancer patients in the palliative phase.
Hoesseini A; Offerman MPJ; van de Wall-Neecke BJ; Sewnaik A; Wieringa MH; Baatenburg de Jong RJ
BMC Palliat Care; 2020 Nov; 19(1):176. PubMed ID: 33234115
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
10. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
[TBL] [Abstract][Full Text] [Related]
11. The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care.
Kishino T; Mori T; Miyashita T; Ouchi Y; Samukawa Y; Fukumura T; Takahashi S; Monden N; Akisada N; Hayashi Y; Nakamura M; Hoshikawa H
Ear Nose Throat J; 2023 Jun; 102(6):379-384. PubMed ID: 33765857
[TBL] [Abstract][Full Text] [Related]
12. Utility of palliative prognostic index and neutrophil-to-lymphocyte ratio in predicting prognosis of end-stage squamous cell carcinoma of head and neck.
Higashino M; Sugimoto K; Onishi S; Okabe K; Yasuda C; Tadokoro H; Kawata R
Head Neck; 2024 Jan; 46(1):23-28. PubMed ID: 37850401
[TBL] [Abstract][Full Text] [Related]
13. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
15. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?
Wan XC; Egloff AM; Johnson J
Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with palliative head and neck cancer.
Ledeboer QC; van der Schroeff MP; Pruyn JF; de Boer MF; Baatenburg de Jong RJ; van der Velden LA
Head Neck; 2011 Jul; 33(7):1021-6. PubMed ID: 20967869
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
18. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
19. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.
Lambrecht M; Van Calster B; Vandecaveye V; De Keyzer F; Roebben I; Hermans R; Nuyts S
Radiother Oncol; 2014 Mar; 110(3):429-34. PubMed ID: 24630535
[TBL] [Abstract][Full Text] [Related]
20. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
